Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

17.2K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
17.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The modulation of the blood-brain barrier by focused ultrasound stimulates oligodendrogenesis.

Acta neuropathologica communications·2026
Same author

Neuroinflammation and neurodegeneration trigger a specific splice form of ribosomal protein S24.

Brain : a journal of neurology·2026
Same author

Creutzfeldt-Jakob disease is an Alzheimer's disease-related dementia.

Trends in molecular medicine·2026
Same author

A self-complementary recombinant adeno-associated virus vector coding for an anchorless prion protein carrying the G127V mutation extends survival in a rodent prion disease model.

bioRxiv : the preprint server for biology·2026
Same author

Plagl1 regulates the retinal progenitor cell to Müller glial cell transition.

PLoS genetics·2026
Same author

Stochastic misfolding drives the emergence of distinct α-synuclein strains.

Neuron·2026

Related Experiment Video

Updated: Oct 13, 2025

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein
14:45

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein

Published on: July 29, 2022

6.2K

Viral alpha-synuclein knockdown prevents spreading synucleinopathy.

Sindhu Menon1, Rikke H Kofoed2, Fadl Nabbouh1

  • 1Tanz Centre for Research in Neurodegenerative Diseases, Toronto, ON M5T 0S8, Canada.

Brain Communications
|November 11, 2021
PubMed
Summary

Silencing the alpha-synuclein (α-syn) gene reduced pathology and motor deficits in synucleinopathies. A moderate 50% reduction in α-syn prevented disease spread, supporting gene therapy for these neurodegenerative conditions.

Keywords:
Parkinson’s diseasegene silencinggene therapymultiple system atrophypathology

More Related Videos

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
10:03

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons

Published on: August 16, 2020

10.8K
A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model
08:24

A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model

Published on: November 25, 2022

2.4K

Related Experiment Videos

Last Updated: Oct 13, 2025

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein
14:45

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein

Published on: July 29, 2022

6.2K
Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
10:03

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons

Published on: August 16, 2020

10.8K
A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model
08:24

A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model

Published on: November 25, 2022

2.4K

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • Alpha-synuclein (α-syn) aggregation is implicated in Parkinson's disease and related synucleinopathies.
  • A prion-like mechanism, where misfolded α-syn templates further aggregation, is hypothesized to drive disease progression.

Purpose of the Study:

  • To investigate if reducing α-syn gene expression can disrupt the propagation of pathological α-syn.
  • To assess the therapeutic potential of α-syn knockdown for synucleinopathies.

Main Methods:

  • Utilized adeno-associated virus serotype-1 encoding microRNA targeting the α-syn gene.
  • Administered unilateral intracerebral injections in a mouse model.
  • Evaluated behavioral, immunohistochemical, and biochemical outcomes.

Main Results:

  • Reduced α-syn gene expression led to decreased α-syn pathology and motor deficits.
  • A 50% reduction in α-syn was sufficient to prevent pathology spread to distal brain regions.
  • Combined data strongly support the efficacy of the intervention.

Conclusions:

  • Alpha-synuclein knockdown gene therapy is a promising approach for treating synucleinopathies.
  • Targeting α-syn expression can effectively mitigate disease progression and symptoms.